As the paragraph descriping shows that 5308-25-8 is playing an increasingly important role.
5308-25-8,5308-25-8, 1-Ethylpiperazine is a piperazines compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated
Compound P42: 5-(Morpholin-4-yl)-2-nitroaniline To the flask 2-amino-3-nitro-6-chloropyridine (1.50 g, 8.47 mmol), potassium carbonate (1.30 g, 9.32 mmol) and morpholine (10.5 ml, 119 mmol) were added. The reaction was carried out under argon flow at 130C overnight. The progress of the reaction was monitored by TLC (system: heptane/ethyl acetate, 1 /1 ). The mixture was cooled to room temperature and poured into the ice-water. A precipitated yellow solid was filtered and dried. 1.789 g of the title product were obtained (yield 94.2%). Compound P46: 5-(4-Ethylpiperazin-1 -yl)-2-nitroaniline; The compound was obtained by the method analogous to that described for Compound P42. Starting from 5-chloro-2-nitroaniline (1.50 g, 8.69 mmol), potassium carbonate (1.32 g, 9.56 mmol) and 1 -ethylpiperazine (1.98 g, 17.3 mmol) w 2 ml of DMF, 2.021 g of the title product in the form of a yellow solid were obtained (yield 92.9%). MS-ESI: (m/z) calculated for C12H19N4O2 [ + H]+: 251.15, found 251.1. 1H NMR (300 MHz, CDC ) delta 7.81 (d, J = 9,6 Hz, 1 H), 6.39 (dd, J = 9,6 Hz;2, 1 Hz 1 H), 6.22 (d, J = 2,1 Hz, 1 H), 3.31 (dd, J = 4,5Hz, 4,8Hz, 4H), 2,44 (dd, J = 4,5Hz, 4,8Hz, 4H) 2,35 (q, J = 7.2 Hz, 2H),1.02 (t, J = 7.2 Hz, 3H) ppm.
As the paragraph descriping shows that 5308-25-8 is playing an increasingly important role.
Reference:
Patent; CELON PHARMA S.A.; ZDZALIK, Daria; LIPNER, Joanna; WIECZOREK, Maciej; DZWONEK, Karolina; YAMANI, Abdellah; DUBIEL, Krzysztof; LAMPARSKA-PRZYBYSZ, Monika; GRYGIELEWICZ, Paulina; STANCZAK, Aleksandra; WO2014/141015; (2014); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics